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Ophthalmology

Advanced age-related macular degeneration (AMD), the leading cause of blindness among people over 50 years of age,
is characterized by atrophic neurodegeneration or pathologic angiogenesis. Early AMD is characterized by extracellular
cholesterol-rich deposits underneath the retinal pigment epithelium (RPE) called drusen or in the subretinal space called
subretinal drusenoid deposits (SDD) that drive disease progression. However, mechanisms of drusen and SDD
biogenesis remain poorly understood. Although human AMD is characterized by abnormalities in cholesterol homeostasis
and shares phenotypic features with atherosclerosis, it is unclear whether systemic immunity or local tissue metabolism
regulates this homeostasis. Here, we demonstrate that targeted deletion of macrophage cholesterol ABC transporters A1
(ABCA1) and -G1 (ABCG1) leads to age-associated extracellular cholesterol-rich deposits underneath the neurosensory
retina similar to SDD seen in early human AMD. These mice also develop impaired dark adaptation, a cardinal feature of
RPE cell dysfunction seen in human AMD patients even before central vision is affected. Subretinal deposits in these
mice progressively worsen with age, with concomitant accumulation of cholesterol metabolites including several
oxysterols and cholesterol esters causing lipotoxicity that manifests as photoreceptor dysfunction and neurodegeneration.
These findings suggest that impaired macrophage cholesterol transport initiates several key elements of early human
AMD, demonstrating the importance of systemic immunity and aging in promoting disease manifestation. Polymorphisms
in genes involved with cholesterol transport and homeostasis […]
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Advanced age-related macular degeneration (AMD), the leading cause of blindness among people
over 50 years of age, is characterized by atrophic neurodegeneration or pathologic angiogenesis.
Early AMD is characterized by extracellular cholesterol-rich deposits underneath the retinal
pigment epithelium (RPE) called drusen or in the subretinal space called subretinal drusenoid
deposits (SDD) that drive disease progression. However, mechanisms of drusen and SDD biogenesis
remain poorly understood. Although human AMD is characterized by abnormalities in cholesterol
homeostasis and shares phenotypic features with atherosclerosis, it is unclear whether systemic
immunity or local tissue metabolism regulates this homeostasis. Here, we demonstrate that
targeted deletion of macrophage cholesterol ABC transporters A1 (ABCA1) and -G1 (ABCG1) leads
to age-associated extracellular cholesterol-rich deposits underneath the neurosensory retina
similar to SDD seen in early human AMD. These mice also develop impaired dark adaptation, a
cardinal feature of RPE cell dysfunction seen in human AMD patients even before central vision
is affected. Subretinal deposits in these mice progressively worsen with age, with concomitant
accumulation of cholesterol metabolites including several oxysterols and cholesterol esters causing
lipotoxicity that manifests as photoreceptor dysfunction and neurodegeneration. These findings
suggest that impaired macrophage cholesterol transport initiates several key elements of early
human AMD, demonstrating the importance of systemic immunity and aging in promoting disease
manifestation. Polymorphisms in genes involved with cholesterol transport and homeostasis
are associated with a significantly higher risk of developing AMD, thus making these studies
translationally relevant by identifying potential targets for therapy.
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Age-related macular degeneration (AMD) is the leading cause of blindness among people over 50 years
of age in the industrialized world (1). Early disease is characterized by cholesterol-rich extracellular
deposits underneath the retinal pigment epithelium (RPE) called drusen (2–4) or in the subretinal space
called subretinal drusenoid deposits (SDD) (5–7). The composition of these deposits is similar to that
of atherosclerotic plaques (3). AMD shares several phenotypic characteristics with atherosclerosis,
including monocytic inflammation, pathologic angiogenesis, and genetic abnormalities in cholesterol homeostasis (4, 8). Although the molecular mechanisms underlying pathological angiogenesis or
RPE atrophy in advanced disease are better understood, there is a paucity of animal models that have
been able to recapitulate early human disease — including anatomic features such as thickening of
Bruch’s membrane (BrM; an acellular lamina underneath the RPE), drusen, or SDD — or functional
characteristics such as an association with age, rod photoreceptor dysfunction (9, 10), or impaired dark
adaptation (11, 12).
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A number of genome-wide association studies (GWAS) have linked AMD to polymorphisms in genes
involved in many facets of cholesterol homeostasis such as LIPC, ApoE, ABCA1, and CETP (13, 14). In
addition, widespread systemic disturbances in cholesterol metabolism as manifested by altered levels of
lipoprotein subtypes have also been associated with AMD (15). Despite reports implicating disruptions in
cholesterol homeostasis in mouse models and in human AMD pathogenesis, it has not been established
whether it is the systemic immune system or local “eye” cells that regulate cholesterol clearance and the
development of the early AMD phenotype. Here, we demonstrate that, in conditional KO mice wherein
both Abca1 and Abcg1 are deleted in macrophages, there is an age-dependent manifestation of several anatomic and functional AMD disease phenotypes, indicating that cholesterol clearance by macrophages plays
a critical role in the early stages of AMD pathogenesis.
Numerous studies have demonstrated that cellular and humoral components of the innate immune
system including macrophages, mononuclear phagocytes, and complement proteins contribute to both the
development and severity of AMD (16–19). Macrophages not only function as antigen-presenting cells and
phagocytic sensors of danger, but they are also important in cholesterol regulation by removing cholesterol from peripheral tissues and transporting it back to the liver through the bloodstream. This process is
termed cholesterol efflux or reverse cholesterol transport (RCT) (3), and ABCA1 and ABCG1 play crucial
roles in macrophage RCT by effluxing cholesterol from cells to extracellular carriers such as ApoA1 and
HDL, respectively (20). In this study, we generated conditional KO mice wherein both Abca1 and Abcg1 are
deleted in macrophages. We evaluated the retinas structurally by biomicroscopy, histology, and electron
microscopy (EM) at 3–12 months of age. In addition, we evaluated retinal function by electrophysiology.

Results
Deletion of Abca1 and Abcg1 in macrophages does not affect the retina at 3 months of age. We have previously reported that mice selectively deficient in Abca1 in macrophages (Abca1fl/fl LysM-Cre–positive [Abca1–m/–m]) demonstrated increased laser-injury induced choroidal neovascularization (CNV), one of the characteristics of
advanced AMD (17). However, when we analyzed treatment-naive Abca1–m/–m mice retinas up to 24 months
of age, we did not detect any functional abnormalities (Supplemental Figure 1, A–F; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.120824DS1) or biomicroscopic
defects (Supplemental Figure 1G) compared with littermate controls (Abca1fl/fl Cre–negative; Abca1F/F) mice.
Because Abca1–m/–m mice macrophages demonstrated significantly increased Abcg1 expression (Supplemental
Figure 1H), we suspected that ABCG1 might compensate for ABCA1, as both ABCA1 and ABCG1 play
crucial roles in macrophage RCT by effluxing cholesterol to extracellular carriers (20). For this reason, and
to directly test whether macrophage cholesterol transport regulates the early AMD phenotype, we generated
conditional KO mice wherein both Abca1 and Abcg1 are deleted in macrophages by crossing Abca1fl/fl and Abcg1fl/fl mice with LysM-Cre mice (17, 21). The deletion of both genes in macrophages of Abca1fl/fl and Abcg1fl/fl
LysM-Cre positive (Abca1/g1–m/–m) mice was confirmed by quantitative PCR (qPCR) (Supplemental Figure
2A). We also confirmed that these mice did not carry the Crb1 gene rd8 mutation (22) (data not shown). EM
at 3 months of age demonstrated large lipid droplets in Abca1/g1–m/–m macrophages but not in macrophages
of littermate control (Abca1fl/fl and Abcg1fl/fl Cre negative; Abca1/g1F/F) mice (Supplemental Figure 2B), consistent with decreased cholesterol efflux in Abca1/g1–m/–m macrophages and confirming findings from previous
studies (17, 23). However, functional analysis at 3 months of age demonstrated that both scotopic and photopic retinal responses (Figure 1, A–C) and dark adaptation curves recorded from Abca1/g1–m/–m mice retinas
were normal (Figure 1D). In addition, in vivo imaging and histological examination of retinal sections of
Abca1/g1–m/–m mice did not show any substantial differences (Figure 1, E and F). These results suggest that
deletion of both ABCA1 and ABCG1 in macrophages does not affect retinal function, vision, or morphology acutely or at a young age.
Abca1/g1–m/–m mice demonstrate RPE abnormalities, BrM thickening, and impaired dark adaptation at 6 months of age.
In order to simulate the human condition, we aged Abca1/g1–m/–m mice and their littermate controls. Upon analysis at 6 months age, we found that scotopic a-waveforms were now slightly attenuated in Abca1/g1–m/–m retinas
compared with littermate controls, confirming scotopic rod photoreceptor dysfunction (Figure 2, A–C). In addition, 6-month-old Abca1/g1–m/–m eyes showed impaired dark adaptation (Figure 2D), consistent with the dysfunction of RPE cells. Notably, this combination of rod photoreceptor dysfunction and impaired dark adaptation is
a key feature of early and intermediate AMD (9–12). Ultrastructural histology revealed disrupted RPE structure
with accumulation of lipid globules in the eyes of Abca1/g1–m/–m mice but not in littermate controls (Figure 2E
insight.jci.org   https://doi.org/10.1172/jci.insight.120824
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Figure 1. Three-month-old Abca1/g1–m/–m retinas do not show functional deficits or morphological abnormalities in the retina and RPE. (A–C) Electroretinography (ERG) of 3-month-old Abca1/g1F/F (n = 5) and Abca1/g1–m/–m mice (n = 6). (A) Scotopic a-wave amplitude. (B) Scotopic b-wave amplitude. (C) Photopic b-wave amplitude. No significant difference was detected by 2-way ANOVA. (D) Dark adaptation curves of 3-month-old Abca1/g1F/F
(n = 5) and Abca1/g1–m/–m mice (n = 4). No significant difference was detected by 2-way ANOVA. (E) Representative fundus images of 3-month-old
Abca1/g1F/F and Abca1/g1–m/–m mice. (F) Representative electron microscopy images of 3-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinal pigmented epithelium (RPE). Scale bar: 1 μm. Values are mean ± SEM.

and Supplemental Figure 3). Abca1/g1–m/–m mice RPE also showed increased BrM thickening (Figure 2, F and G),
which is another morphological characteristic of human eyes with AMD.
Retinal neurodegeneration of Abca1/g1–m/–m mice increases in severity and affects cone photoreceptors at 12 months of
age. We next examined whether further aging would recapitulate additional features of human AMD in the
mouse eye. At 12 months of age, both scotopic a- and b-waveforms were significantly attenuated in Abca1/g1–m/–m
retinas compared with littermate controls (Figure 3, A and B), confirming additional rod neurodegeneration. In
addition, photopic responses were also significantly attenuated (Figure 3C), suggesting cone photoreceptor dysfunction. Dark adaptation was also further impaired (Figure 3D). Biomicroscopic examination of Abca1/g1–m–/m
eyes now showed yellowish white lesions scattered throughout the retina (Figure 3E).
Subretinal deposits of Abca1/g1–m/–m mice progressively increase in number with age. The yellowish white
lesions throughout the retina corresponded to hyperreflective outer retinal focal deposits underneath the
neurosensory retina on optical coherence tomography (OCT) imaging (Figure 4A). Quantitative analysis
of these SD in Abca1/g1–m–/m mice showed progressive increase with age, with a significant number of SD
insight.jci.org   https://doi.org/10.1172/jci.insight.120824
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Figure 2. Six-month-old Abca1/g1–m/–m retinas demonstrate decreased scotopic responses and impaired dark adaptation associated with disrupted RPE
morphology and Bruch’s membrane thickening. (A–C) ERG of 6-month-old Abca1/g1F/F (n = 4) and Abca1/g1–m/–m mice (n = 5). (A) Scotopic a-wave amplitude. (B) Scotopic b-wave amplitude. (C) Photopic b-wave amplitude. **P < 0.01 by 2-way ANOVA with post hoc Bonferroni’s multiple comparison test. (D)
Dark adaptation curves of 6-month-old Abca1/g1F/F (n = 4) and Abca1/g1–m/–m mice (n = 8). *P < 0.05, **P < 0.01, and ***P < 0.001 by 2-way ANOVA with
post hoc Bonferroni’s multiple comparison test. (E and F) Representative electron microscopy images of 6-month-old Abca1/g1F/F and Abca1/g1–m/–m mice
retinal pigmented epithelium (RPE). (E) Illustration of dysmorphic changes in 6-month-old Abca1/g1F/F and Abca1/g1–m/–m mice RPE. Note the vacuoles
(asterisks), photoreceptor disk fragments (yellow arrowhead), and lipid droplets (red arrowheads) in Abca1/g1–m/–m mice RPE. Scale bar: 1 μm. (F) Thickness
change of 6-month-old Abca1/g1F/F (n = 6) and Abca1/g1–m/–m (n = 4) mice Bruch’s membrane (BrM). Note the white bars, which represent BrM thickness.
Scale bar: 1 μm. (G) Quantification of BrM thickness. **P < 0.01 by 2-tailed unpaired t test. Values are mean ± SEM.

by 12 months of age compared with littermate controls (Figure 4B). EM confirmed that the deposits were
subretinal and contained lipid globules, degenerative vacuoles, and cellular debris (Figure 4C). Some SD
were associated with infiltration of mononuclear cells (Figure 4C).
Infiltrating cells in the subretinal space are Iba1- or F4/80-positive monocytic cells. To investigate the identity of the cellular component of SD, we performed IHC with a monocyte/microglial marker (Iba1), as
well as qPCR of the retina/RPE/choroid complex. The number of Iba1-positive cells in the subretinal
space, visualized by IHC, were significantly increased at 12 months of age in Abca1/g1–m/–m mice (Figure 5, A and B). Increased Iba1 expression was also confirmed in the retina/RPE/choroid complex of
insight.jci.org   https://doi.org/10.1172/jci.insight.120824
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Figure 3. Neurodegeneration of aged Abca1/g1–m/–m (12-month-old) retinas increases in severity and extends to photopic dysfunction with significant
subretinal deposits. (A–C) Electroretinography (ERG) of 12-month-old Abca1/g1F/F (n = 5) and Abca1/g1–m/–m mice (n = 5). (A) Scotopic a-wave amplitude. (B)
Scotopic b-wave amplitude. (C) Photopic b-wave amplitude. *P < 0.05, **P < 0.01, and ***P < 0.001 by 2-way ANOVA with post hoc Bonferroni’s multiple
comparison test. (D) Dark adaptation curves of 12-month-old Abca1/g1F/F (n = 8) and Abca1/g1–m/–m (n = 5). *P < 0.05, **P < 0.01, and ***P < 0.001 by 2-way
ANOVA with post hoc Bonferroni’s multiple comparison test. (E) Representative fundus images of 12-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinas. Note the white yellowish dots of Abca1/g1–m/–m mice retinas.

Abca1/g1–m/–m mice by qPCR (Figure 5C). IHC with another monocyte/microglial marker (F4/80) also
showed increased F4/80-positive cells in the subretinal space (Figure 5, D and E). Increased F4/80
expression was also confirmed in the retina/RPE/choroid complex of Abca1/g1–m/–m mice by qPCR
(Figure 5F). These results indicate that infiltrating cells in the subretinal space are likely macrophages/
microglia. Recent histological analysis of human SDD describes the presence of bloated macrophage
clusters in these lesions (7). As such, SD of old Abca1/g1–m/–m mice are phenotypically similar to SDD
seen in human AMD.
Aged Abca1/g1–m/–m mice demonstrate lipid accumulation underneath the retina and within RPE. We further
analyzed 12-month-old Abca1/g1–m/–m mice for the precise distribution of lipid deposits and for specific
composition. Oil Red O (ORO) staining demonstrated focal lipid accumulations within the RPE, as
well as in the subretinal space (Figure 6A), consistent with the findings on EM ultrastructural analysis.
Analysis of the retina/RPE/choroid complex by liquid chromatography–tandem mass spectrometry
(LC-MS/MS) revealed increased free cholesterol and several cholesterol metabolites (3β,5α,6β-cholestanetriol [C-triol] and 4β-hydroxycholesterol [4β-HC]) (Figure 6B), as well as several cholesterol ester
species (Figure 6C). These findings demonstrate that the SD and lipids within RPE are composed of
cholesterol and cholesterol esters, as well as cholesterol oxidation products that suggest a highly oxidative environment within the lipid deposits.

insight.jci.org   https://doi.org/10.1172/jci.insight.120824
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Figure 4. Subretinal deposits contain lipid globules and degenerative vacuoles. (A) Representative optical coherence tomography (OCT) images of 12-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinas. Note the subretinal hyperreflective deposits in Abca1/g1–m/–m mice retinas (red
arrow) corresponding to fundus yellowish white dots. POS, photoreceptor outer segment. (B) Quantification of subretinal deposits in 3-, 6-, and
12-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinas. Abca1/g1F/F, n = 10, 10, and 15; Abca1/g1–m/–m, n = 13, 24, and 16, respectively. ***P < 0.001
by 2-way ANOVA with post hoc Bonferroni’s multiple comparison test. (C) Representative electron microscopy images of 12-month-old Abca1/g1F/F
and Abca1/g1–m/–m mice retinas. Note the vacuoles (asterisk) and lipid globules (red arrowheads) within the subretinal deposit in Abca1/g1–m/–m mice
retinas. Scale bar: 1 μm. Values are mean ± SEM.

Discussion
Here, we have demonstrated that, in conditional KO mice wherein macrophage cholesterol efflux capacities are disabled (Abca1/g1–m/–m), there is an age-dependent manifestation of several early and intermediate
anatomic AMD disease phenotypes, including cellular and noncellular SD similar to SDD, increased BrM
thickening, and accumulation of free cholesterol, cholesterol metabolites, and cholesteryl esters. In addition,
KO mice demonstrate several key features of early functional degradation seen in human AMD, including
impaired dark adaptation and rod photoreceptor dysfunction.
Although we generated macrophage-specific conditional KO mice by crossing Abca1fl/fl and Abcg1fl/fl
mice with LysM-Cre mice, it has been established that LysM-Cre promotes significant deletion not only
in macrophages, but also in neutrophils (24). A previous study demonstrated variable deletion of Abca1
and Abcg1 in neutrophils (25). Thus, we cannot exclude the possibility that the deletion of Abca1 and Abcg1
in neutrophils might also affect the retinal phenotype. However, in addition to the fact that macrophages,
but not neutrophils, play crucial roles in RCT from tissues, we demonstrated increased gene expression
of macrophage markers Iba1 and F4/80, but not the neutrophil marker Gr-1, in the eyes of 12-month-old
Abca1/g1–m/–m mice (Supplemental Figure 4). For these reasons, we conclude that the retinal phenotypes
we observed at 12 months of age are mainly associated with dysfunctional Abca1- and Abcg1-deficient
macrophages, although further study might elucidate this more precisely.
insight.jci.org   https://doi.org/10.1172/jci.insight.120824
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Figure 5. Infiltrated cells in subretinal space are IBA1 and F4/80 positive. (A) Representative Iba1 IHC staining of 12-month-old Abca1/g1F/F and
Abca1/g1–m/–m mice retinas. Red, Iba1; blue, DAPI. Scale bar: 50 μm. INL, inner nuclear layer; ONL, outer nuclear layer; POS, photoreceptor outer segment. (B) Quantification of Iba1-positive cells in subretinal space. Abca1/g1F/F, n = 5; Abca1/g1–m/–m, n = 5. **P < 0.01 by 2-tailed Mann-Whitney U test.
(C) qPCR quantification of Iba1 expressions in the retina/RPE/choroid complex. Abca1/g1F/F, n = 7; Abca1/g1–m/–m, n = 7. ***P < 0.001 and by 2-tailed
unpaired t test. (D) Representative IHC staining of 12-month-old Abca1/g1F/F
and Abca1/g1–m/–m mice retinas. Red, F4/80; blue, DAPI. Scale bar: 50 μm.
F/F
(E) Quantification of F4/80-positive cells in the subretinal space. Abca1/g1 , n = 5; Abca1/g1–m/–m, n = 5. **P < 0.01 and by 2-tailed Mann-Whitney
test. (F) qPCR quantification of F4/80 expressions in the retina/RPE/choroid complex. Abca1/g1F/F, n = 7; Abca1/g1–m/–m, n = 7. ***P < 0.001 and by
2-tailed unpaired t test. Values are mean ± SEM.

Polymorphisms in genes involved with cholesterol transport and homeostasis are associated with
a significantly higher risk of developing AMD (13, 14), thus making these studies translationally relevant by identifying potential targets for therapy. Although there are no previous reports of ABCG1
polymorphisms associated with increased AMD risk, we found that, in Abca1–m/–m mice, ABCG1 might
compensate for the lack of ABCA1. As such, we wanted to effectively neutralize the efflux pathway by
the deletion of both Abca1 and Abcg1 in order to examine its effect on the retinal phenotype with aging.
We are also aware that ABCA1 polymorphisms associated with AMD risk are HDL elevating (26–30).
HDL carrier capacity is not just limited by level but by the size and quality of the particles available at
the retinal choroidal interphase. In addition, these findings also suggest that there is a complex interplay
between systemic lipid profiles and local lipid profiles in AMD.
Although we are proposing our mouse model as an early-stage AMD model, an important feature of AMD
that is lacking in this model is the development of sub-RPE drusen and may represent metabolic differences
between the mouse and human retina and RPE. However, although our mouse model (Abca1/g1–m/–m mice) does
not demonstrate all the features of human disease, age is a key variable here, just as in human AMD that only
affects people over the age of 50 years. Thus, these findings suggest that maintenance of cholesterol homeostasis
and macrophage-mediated cholesterol efflux may be critical pathways that initiate the development of AMD.
These pathways deserve further investigation in order to determine whether pharmacotherapeutic interventions
targeting these pathways, either locally or systemically, might prove efficacious in either preventing the development of early AMD or the progression to advanced stages of disease where vision loss is imminent.
insight.jci.org   https://doi.org/10.1172/jci.insight.120824
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Figure 6. Lipid analysis of Abca1/g1–m/–m mice eyes at 12 months of age demonstrates focal subretinal and RPE deposits with increased cholesterol
metabolites. (A) Representative Oil Red O staining of 12-month-old Abca1/g1F/F and Abca1/g1–m/–m mice retinas. Note the lipid deposits within the
RPE (yellow arrowheads) or subretinal space (red arrowhead). Scale bar: 20μm. (B) Analyses of free cholesterol, 3β,5α,6β-cholestanetriol (C-triol),
4β-hydroxycholesterol (4β-HC), 24-hydroxycholesterol (24-HC), 25-HC, 27-HC, and 7-ketocholesterol in retina/RPE/choroid complex at 12 months of
age (normalized peak area ratio/mg wet tissue weight). Abca1/g1F/F, n = 7; Abca1/g1–m/–m, n = 6. *P < 0.05 and **P < 0.01 by 2-tailed unpaired t test. (C)
Analyses of cholesterol esters (CE) in retina/RPE/choroid complex at 12 months of age (normalized peak area ratio/mg wet tissue weight). Abca1/g1F/F,
n = 7; Abca1/g1–m/–m, n = 6. **P < 0.01 and ***P < 0.001 by 2-tailed unpaired t test. Values are mean ± SEM.

Methods
Supplemental Methods are available online with this article.
Animals. All mice were housed in a temperature-controlled room under a 12-hour light/dark cycle, with free
access to food and water. Abca1fl/fl and Abcg1fl/fl (Abca1/g F/F) mice were previously characterized (23) and were
purchased commercially (The Jackson Laboratory). To generate mice lacking both Abca1 and Abcg1 specifically
from macrophages, we crossed Abca1/g1F/F mice with mice carrying 1 copy of the LysM-Cre transgene, which
were purchased commercially (The Jackson Laboratory) and have been previously characterized (17, 21, 23).
RNA isolation and qPCR. Total RNA was extracted using RNeasy Micro Plus kit (Qiagen) according to
the manufacturer’s instructions. To synthesize cDNA, total RNA was added to the High Capacity cDNA
Reverse Transcription Kit (Thermo Fisher Scientific) and reverse-transcribed according to manufacturer’s
insight.jci.org   https://doi.org/10.1172/jci.insight.120824
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instructions. qPCR was performed in duplicate using the StepOnePlus Real Time PCR system (Thermo
Fisher Scientific) using TaqMan Real-Time PCR Assays (Thermo Fisher Scientific), and the mRNA was
quantified using the ΔΔCT method with gapdh or bactin as the internal control.
Transmission EM. We performed transmission EM as previously described (31). Briefly, for ultrastructural analyses, samples were fixed in 2% paraformaldehyde (PFA)/2.5% glutaraldehyde (Polysciences Inc.)
in 100 mM sodium cacodylate buffer, pH 7.2, for 2 hours at room temperature and then overnight at
4°C. Samples were washed in sodium cacodylate buffer at room temperature and postfixed in 1% osmium
tetroxide (Polysciences Inc.) for 1 hour. Samples were then rinsed extensively in dH20 prior to en bloc staining with 1% aqueous uranyl acetate (Ted Pella Inc.) for 1 hour. Following several rinses in dH2O, samples
were dehydrated in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella Inc.). Sections
of 95 nm were cut with a Leica Ultracut UCT ultramicrotome (Leica Microsystems Inc.), stained with uranyl acetate and lead citrate, and viewed on a JEOL 1200 EX transmission electron microscope (JEOL USA
Inc.) equipped with an AMT 8 megapixel digital camera and AMT Image Capture Engine V602 software
(Advanced Microscopy Techniques).
To measure BrM thickness, we used 25,000× EM pictures. We set 5 measurement points that were
arranged at equal 500-nm intervals and measured BrM thickness using Adobe Photoshop CS 5.1 (Adobe).
We took averages of each picture as representative BrM thickness.
Electroretinography (ERG). ERG was performed as previously described (32). Briefly, A UTAS BigShot
System (LKC Technologies Inc.) was used. Mice were dark adapted overnight. Under red light illumination, mice were anesthetized with an i.p. injection of 86.9 mg/kg ketamine and 13.4 mg/kg xylazine.
Pupils were dilated with 1% atropine sulfate eye drops (Bausch & Lomb). Body temperature was maintained at 37°C with a heating pad. Contact lens electrodes were placed bilaterally with appropriate reference and ground electrodes. The stimulus consisted of a full-field white light flash (10 μs) in darkness or in
the presence of dim (30.0 candela [cd]/m2) background illumination after 10-minute adaptation time. Raw
data were processed using MATLAB software (MathWorks). The amplitude of the a-wave was measured
from the average pretrial baseline to the most negative point of the average trace, and the b-wave amplitude
was measured from that point to the highest positive point.
For testing dark adaptation, we modified the protocol as previously described (33). Briefly, we used
a UTAS BigShot System (LKC Technologies Inc.) to get scotopic a-waves. A bright LED light (150,000
lux) was applied to both eyes for 15 seconds to photobleach an estimated 90% of the visual pigment. The
recovery of the ERG responses was monitored at fixed post-bleach time points within 100 minutes after the
bleach. The sensitivity was calculated as the ratio of dim flash response amplitude and the corresponding
flash intensity in the linear range of the intensity-response curve. The post-bleach sensitivities were normalized to their dark-adapted prebleach level.
Retinal imaging. We performed digital color fundus photography and OCT as previously described (21)
using the Micron III animal fundus camera equipped with 830 nm OCT (Phoenix Research Labs). Prior
to fundus imaging and OCT, we anesthetized mice with an i.p. injection of 86.9 mg/kg ketamine and 13.4
mg/kg xylazine and administered 1.0% tropicamide eye drops (Bausch & Lomb) to dilate the pupils.
Cryopreservation. Enucleated posterior poles were fixed in 4% PFA followed by cryopreservation in
Tissue-Tek OCT compound (Sakura Finetek). Cryosections (10-μm thick) were cut and collected on gelatin-coated slides and stored at –20°C until use.
ORO staining. ORO (0.7%, MilliporeSigma) staining solution was prepared in 100% propylene glycol
(MilliporeSigma) by heating the solution to 90°C. The staining protocol was as follows. Slides were rinsed
with water and placed in 100% propylene glycol for 5 minutes, followed by staining overnight in preheated
(60°C) ORO solution. Slides were next differentiated in 85% propylene glycol for 1 minute at room temperature, followed by 2 rinses in water. Slides were dried at room temperature, mounted in Aqua-Poly/
Mount (Polysciences Inc.), and imaged using a ZEISS Axionplan 2 light microscope.
IHC. Retinal cryosections were incubated with a blocking solution of 10% normal goat serum
(NGS) in PBTA (PBS, 0.5% BSA, 0.1% Triton, 0.05% Sodium Azide) for 2 hours at room temperature.
After the blocking, sections were probed with either anti-Iba1 (Wako, catalog 019-19741; 1:200 in
10% NGS-PBTA) or anti-F4/80 antibodies (Bio-Rad, catalog MCA497GA; 1:500 in 10% NGS-PBTA)
overnight at 4 °C. The next day, anti-Iba1 sections were incubated in goat anti–rabbit-568 (Thermo
Fisher Scientific, catalog A11011; 1:200 in 5% NGS-PBTA) and anti-F4/80 sections were incubated
in goat anti–rat-568 (Thermo Fisher Scientific, catalog A11077; 1:200 in 5% NGS-PBTA), both for
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2 hours at room temperature. Nuclei were counterstained with DAPI (MilliporeSigma). All sections
were examined under a confocal microscope equipped with a digital camera (C2si confocal microscope, Nikon Corporation). To count Iba1- or F4/80-positive cells in the subretinal space, 3 slides per
animal were stained with Iba1 and F4/80, and 3 equidistant fields of view were identified in the nasal,
central, and temporal regions, per slide. The number of staining positive cells were counted in each
field of view and their mean was taken (n). The n values from 3 slide were averaged as cell counts/field
in the subretinal space.
Analyses of oxysterols, free cholesterol, and cholesterol esters in retina/RPE/choroid complex. Each retina/
RPE/choroid complex was homogenized with 50-fold excess volume of PBS buffer using Omni Bead
Ruptor 24 (Omni International Inc.). All analytes listed above in 50 μl of the mouse retina homogenate
were extracted with 200 μl of methanol. Prior to the extraction, triol-d7 (2 ng), 7-ketocholesterol-d7 (2
ng), 24-hydroxycholesterol-d7 (24-HC-d7; 2 ng), 27-HC-d5 (2 ng), 4β-HC-d7 (2 ng), cholesterol esters
(18:2)-d7 (CE[18:2]-d7;200 ng), and cholesterol-d7 (1 μg) were added as the internal standards to the
homogenate samples. All oxysterols and cholesterol, as well as their deuterated standards, were derivatized with N,N-dimethylglycine (DMG) to increase the MS sensitivity. Cholesterol esters were not
derivatized for the MS analyses.
Oxysterol analysis was performed with a Shimadzu 20AD HPLC system and a Shimadzu SIL 20AC
autosampler coupled to a triple quadrupole mass spectrometer (API-6500Qtrap+, Thermo Fisher Scientific) operated in multiple reaction monitoring (MRM) mode. The positive ion electrospray ionization (ESI)
mode was used for detection of the DMG derivatized oxysterols. All samples were injected in duplicate for
data averaging. Data processing was conducted with Analyst 1.6.3 (Thermo Fisher Scientific).
The analysis of free cholesterol and 2 CEs (CE[16:0] and CE[18:0]) was performed with a Shimadzu
20AD HPLC system: a LeapPAL autosampler coupled to a triple quadrupole mass spectrometer (API
4000) operated with positive ion MRM mode. The data processing was conducted with Analyst 1.5.1
(Thermo Fisher Scientific).
The analysis of the rest of the CEs (CE[16:2], CE[18:1], CE[18:2], and CE[20:4]) was performed with
a Shimadzu 10AD HPLC system and a Shimadzu SIL 20AC autosampler coupled to a triple quadrupole
mass spectrometer (TSQ Quantum Ultra) operated in MRM mode. The data processing was conducted
with XCalibur.
The relative quantification data is reported as peak area ratios of analytes to their internal standards
normalized to wet weights (mg) of retina/RPE/choroid complex.
Statistics. We performed statistical testing with GraphPad Prism (Version 6.0), using the appropriate
test for each dataset (2-way ANOVA, 2-way ANOVA with post hoc Bonferroni’s multiple comparison test,
2-tailed unpaired t test, or 2-tailed Mann-Whitney U test). We defined statistical significance as a P < 0.05.
Values are mean ± SEM.
Study approval. All animal experiments were reviewed and approved by the IACUC of Washington
University in St. Louis and performed in accordance with the Washington University School of Medicine
Animal Care and Use guidelines.
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